Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.712776965598907e-46,28.6159279533816,2993.4302149000455,"['RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPS6KA2', 'RPL35', 'RPL38', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPS15A', 'RPL14', 'RPL13', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS23']",1.6707496345195082e-43,0,0,58
2,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,5.486574717838602e-05,4.751089845826688,46.61114332104571,"['SREBF1', 'CDKN1A', 'CEBPB', 'NOTCH1', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'JUNB', 'HES5']",0.012344793115136855,0,0,12
3,Vitamin D Receptor Pathway WP2877,0.00011872629418386645,3.7363925640596216,33.77209321895321,"['CDKN1A', 'SERPINB1', 'GADD45A', 'HILPDA', 'NFATC2', 'TNFRSF11B', 'ATP2C2', 'CYP3A5', 'CEACAM1', 'BCL6', 'S100A6', 'CD9', 'PRKCQ', 'JUNB']",0.0170596489595717,0,0,14
4,Differentiation Pathway WP2848,0.0001516413240850818,8.282346723044398,72.83489525960167,"['NT5E', 'KITLG', 'WNT2B', 'NOTCH1', 'EGF', 'HGF', 'WNT7B']",0.0170596489595717,0,0,7
5,Nuclear Receptors Meta-Pathway WP2882,0.00022269051401612984,2.3063543599257885,19.3958118698187,"['MGST1', 'IRS2', 'DBI', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'AKAP13', 'HES1', 'JUNB', 'CBR3', 'SREBF1', 'NQO1', 'JUN', 'GADD45B', 'SLC6A16', 'HGF', 'SLC39A11', 'NRG1', 'SLC39A14', 'SLC2A9', 'SCD', 'SPINK13', 'ANGPTL4', 'GCLM', 'HSPA1A', 'FKBP5', 'FTL']",0.020042146261451687,0,0,27
6,Spinal Cord Injury WP2431,0.0003281180848194473,3.326995630395396,26.689614744356728,"['BTG2', 'IL1R1', 'GADD45A', 'PLA2G5', 'ICAM1', 'GFAP', 'TNFSF13B', 'LGALS3', 'ZFP36', 'VCAN', 'GAP43', 'COL4A1', 'CCNG1', 'SLIT3']",0.022564343550114527,0,0,14
7,Overview of nanoparticle effects WP3287,0.00035100089966844816,12.991879350348027,103.34678551888437,"['CCND3', 'COL4A1', 'LAMA3', 'FN1', 'PIK3CD']",0.022564343550114527,0,0,5
8,"GPCRs, Class A Rhodopsin-like WP455",0.0005013778057696579,4.205593405352505,31.95473221495348,"['P2RY12', 'OXTR', 'EDNRA', 'GPR161', 'P2RY14', 'GPR87', 'GPR171', 'GPR22', 'CHRM5', 'ACKR4']",0.028202501574543258,0,0,10
9,Hematopoietic Stem Cell Differentiation WP2849,0.0006302986824908442,6.071550387596899,44.74317798032941,"['HES6', 'CIITA', 'KITLG', 'NOTCH1', 'PIM1', 'NFATC2', 'RUNX1']",0.03151493412454221,0,0,7
10,Adipogenesis WP236,0.00074772657959286,2.883181441590721,20.754504286470468,"['SREBF1', 'CDKN1A', 'CEBPB', 'GADD45B', 'CEBPD', 'GADD45A', 'IRS2', 'SFRP4', 'SOCS3', 'KLF6', 'SCD', 'NAMPT', 'PNPLA3', 'ID3', 'RXRG']",0.0336476960816787,0,0,15
11,Complement and Coagulation Cascades WP558,0.0008390287577525948,7.090909090909091,50.22679226518696,"['CPB2', 'C1S', 'C1R', 'PROS1', 'SERPING1', 'F3']",0.03432390372624251,0,0,6
12,Development and heterogeneity of the ILC family WP3893,0.0014636708039611726,12.977983777520278,84.7048050908396,"['NFIL3', 'IL7', 'ZBTB16', 'IL18']",0.054887655148543976,0,0,4
13,Type II interferon signaling (IFNG) WP619,0.002870926847239147,5.198141695702671,30.425348983180502,"['SOCS3', 'CIITA', 'HLA-B', 'GBP1', 'ICAM1', 'PSMB9']",0.09937823701981663,0,0,6
14,Vitamin A and carotenoid metabolism WP716,0.003711165157942631,4.872822299651568,27.27030848782089,"['RBP2', 'RBP1', 'BCO2', 'BCO1', 'RXRG', 'RLBP1']",0.11928745150529886,0,0,6
15,Globo Sphingolipid Metabolism WP1424,0.005645209289905578,5.409899458623356,28.006768219290425,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'A4GALT', 'ST6GALNAC5']",0.16300242426039097,0,0,5
16,Differentiation of white and brown adipocyte WP2895,0.005795641751480568,7.414004303923192,38.186934343673556,"['SMAD1', 'CEBPB', 'SMAD9', 'SLC7A10']",0.16300242426039097,0,0,4
17,Transcriptional cascade regulating adipogenesis WP4211,0.006263596186865271,12.96412037037037,65.76699285552363,"['SREBF1', 'CEBPB', 'CEBPD']",0.1647510085725734,0,0,3
18,Breast cancer pathway WP4262,0.006590040342902936,2.223911651728553,11.168919776118813,"['JUN', 'CDKN1A', 'NOTCH1', 'WNT2B', 'GADD45B', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'PIK3CD', 'WNT7A', 'GADD45G', 'SFRP4', 'HES1', 'HES5']",0.1647510085725734,0,0,15
19,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.007830527849318869,3.1526440187674183,15.289457641130543,"['SREBF1', 'SQLE', 'HMGCS1', 'SCD', 'MSMO1', 'DHCR24', 'DHCR7', 'HSD17B7']",0.17039501123336334,0,0,8
20,Genotoxicity pathway WP4286,0.007830527849318869,3.1526440187674183,15.289457641130543,"['ACTA2', 'ITPKC', 'BTG2', 'CDKN1A', 'RPS27', 'CEBPD', 'GADD45A', 'TRIM22']",0.17039501123336334,0,0,8
21,Nonalcoholic fatty liver disease WP4396,0.00795176719089029,2.0548148148148146,9.933716781435852,"['COX8A', 'SREBF1', 'XBP1', 'JUN', 'NDUFA7', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'PIK3CD', 'IRS2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX7A1', 'TNFRSF1A', 'SOCS3', 'UQCRQ']",0.17039501123336334,0,0,17
22,miRNA regulation of DNA damage response WP1530,0.008473527951914217,2.855961112058673,13.625243074393873,"['CDKN1A', 'CCND3', 'CCNE2', 'GADD45B', 'GADD45A', 'CCNG1', 'TNFRSF10B', 'PML', 'GADD45G']",0.1733221626527908,0,0,9
23,Gene regulatory network modelling somitogenesis  WP2854,0.01037938924431455,9.722222222222221,44.410462081192335,"['LFNG', 'NOTCH1', 'HES1']",0.1949268730347784,0,0,3
24,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.010471709838407244,2.97196075170464,13.54940075836141,"['BEX3', 'SOCS3', 'NQO1', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'NRG1', 'YBX3']",0.1949268730347784,0,0,8
25,The influence of laminopathies on Wnt signaling WP4844,0.010829270724154356,3.7109673137547703,16.79399207374754,"['SREBF1', 'CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'HES5']",0.1949268730347784,0,0,6
26,Vitamin B12 metabolism WP1533,0.011820133316634424,4.3267594740912605,19.20194648359433,"['SERPINA3', 'HBB', 'SOD2', 'LDLR', 'ICAM1']",0.20026035031818284,0,0,5
27,Selenium Micronutrient Network WP15,0.012015621019090969,2.8891475876342,12.774503940829499,"['SERPINA3', 'SELENOM', 'HBB', 'SOD2', 'SEPHS2', 'LDLR', 'ICAM1', 'SELENOH']",0.20026035031818284,0,0,8
28,Osteoblast differentiation WP4787,0.013181461711973173,2.3474222460548493,10.161859100730542,"['HES6', 'SMAD1', 'NOTCH1', 'WNT2B', 'FZD4', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'PRKCQ', 'FGFR3']",0.21184492037099745,0,0,11
29,NRF2 pathway WP2884,0.015031017264640519,2.2007412898443293,9.237918336958632,"['SLC2A9', 'NQO1', 'SLC6A16', 'HGF', 'SLC39A11', 'NRG1', 'GCLM', 'SLC5A3', 'SLC39A14', 'FTL', 'CBR3', 'HSPA1A']",0.23323992307200805,0,0,12
30,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.01572883617414853,7.777083333333334,32.29246855991785,"['CDKN1A', 'FAM20C', 'FGFR3']",0.23593254261222793,0,0,3
31,Aryl Hydrocarbon Receptor Pathway WP2873,0.01782430232906966,3.817046540193804,15.371981021219554,"['NQO1', 'JUN', 'MGST1', 'HES1', 'JUNB']",0.24188930194996744,0,0,5
32,Complement system WP2806,0.018089607616339206,3.2462253193960513,13.025211833804477,"['RPS19', 'C1S', 'C1R', 'PROS1', 'SERPING1', 'ICAM1']",0.24188930194996744,0,0,6
33,IL-18 signaling pathway WP4754,0.018615786919446,1.7519393358319533,6.9792800935083035,"['JUN', 'BTG2', 'CEBPB', 'NRN1', 'RGS16', 'FN1', 'IL18', 'HSPB1', 'TNFRSF11B', 'ICAM1', 'TNFRSF1A', 'ACTA2', 'SOCS3', 'KITLG', 'TMSB4X', 'NFKBIZ', 'KIFC3', 'PTPN7', 'RPS11', 'ARF6']",0.24188930194996744,0,0,20
34,Cholesterol Biosynthesis Pathway WP197,0.019041156063535538,4.716317286421574,18.68205216949982,"['SQLE', 'HMGCS1', 'MSMO1', 'DHCR7']",0.24188930194996744,0,0,4
35,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.019041156063535538,4.716317286421574,18.68205216949982,"['SREBF1', 'HMGCS1', 'SCD', 'LDLR']",0.24188930194996744,0,0,4
36,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.01951977967611644,2.1109530583214795,8.309401487845394,"['ATP5IF1', 'COX8A', 'NDUFA7', 'UQCRQ', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX7A2', 'UQCR11', 'UQCR10', 'SLC25A5', 'COX7A1']",0.24188930194996744,0,0,12
37,DNA damage response WP707,0.019888675938108436,2.59930151338766,10.183035975173654,"['CDKN1A', 'CCND3', 'CCNE2', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'PML', 'GADD45G']",0.24188930194996744,0,0,8
38,Mitochondrial CIV Assembly WP4922,0.021108228697097907,3.11609756097561,12.02219209604262,"['COX8A', 'COA3', 'NDUFA4', 'COX7A2', 'COX14', 'PET117']",0.24996586614984365,0,0,6
39,IL1 and megakaryocytes in obesity WP2865,0.02235057427179617,6.480324074074074,24.631084923403908,"['IL1R1', 'IL18', 'ICAM1']",0.2514439605577069,0,0,3
40,Peptide GPCRs WP24,0.02235057427179617,6.480324074074074,24.631084923403908,"['OXTR', 'EDNRA', 'TAC4']",0.2514439605577069,0,0,3
41,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.02444997598600777,2.9959796301259716,11.118458036336367,"['IFITM3', 'BST2', 'JUN', 'IFITM2', 'RPS6KA2', 'JUNB']",0.2674366950931454,0,0,6
42,DNA damage response (only ATM dependent) WP710,0.025070483519146307,2.1044529961517315,7.757148597657835,"['CCND3', 'JUN', 'CDKN1A', 'WNT2B', 'BCL6', 'SHC1', 'WNT7B', 'PIK3CD', 'WNT7A', 'SOD2', 'LDLR']",0.2674366950931454,0,0,11
43,Signal transduction through IL1R WP4496,0.02555506197556722,3.414641592380022,12.521217075279635,"['JUN', 'IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14']",0.2674366950931454,0,0,5
44,Small cell lung cancer WP4658,0.02714022651478363,2.1672500972384285,7.816703884684753,"['CDKN1A', 'CCNE2', 'GADD45B', 'COL4A1', 'GADD45A', 'LAMA3', 'FN1', 'PIK3CD', 'RXRG', 'GADD45G']",0.2775704984466507,0,0,10
45,ID signaling pathway WP53,0.030254411031789837,5.5540674603174605,19.428757173738905,"['SREBF1', 'ID3', 'ELK3']",0.2959670644414223,0,0,3
46,miR-509-3p alteration of YAP1/ECM axis WP3967,0.030254411031789837,5.5540674603174605,19.428757173738905,"['EDNRA', 'PBX3', 'FN1']",0.2959670644414223,0,0,3
47,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.038949568787899784,1.8805326569435636,6.103245377457921,"['CLDN11', 'CLDN20', 'NOTCH1', 'WNT2B', 'COL4A1', 'SHC1', 'FZD4', 'MMP15', 'WNT7B', 'FN1', 'PIK3CD', 'WNT7A']",0.36675995579532905,0,0,12
48,BMP Signaling Pathway in Eyelid Development WP3927,0.039426465246275966,4.859375,15.711904565933601,"['SMAD1', 'JUN', 'NOTCH1']",0.36675995579532905,0,0,3
49,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.03993608407549138,2.391738066095471,7.7025326507567735,"['SFRP4', 'CCND3', 'JUN', 'WNT2B', 'WIF1', 'WNT7B', 'WNT7A']",0.36675995579532905,0,0,7
50,Notch Signaling WP268,0.041276546591002404,2.5955865272938445,8.273330359298702,"['LFNG', 'NUMBL', 'NOTCH1', 'DTX3L', 'HES1', 'HES5']",0.3714889193190216,0,0,6
51,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.04453506435291057,8.632755298651253,26.86063196454039,"['SMAD1', 'SMAD9']",0.37812790488320297,0,0,2
52,Liver X receptor pathway WP2874,0.04453506435291057,8.632755298651253,26.86063196454039,"['SREBF1', 'SCD']",0.37812790488320297,0,0,2
53,PTF1A related regulatory pathway WP4147,0.04453506435291057,8.632755298651253,26.86063196454039,"['NOTCH1', 'HES1']",0.37812790488320297,0,0,2
54,Folate Metabolism WP176,0.046702649709631554,2.819782104307475,8.63968372054552,"['SERPINA3', 'HBB', 'SOD2', 'LDLR', 'ICAM1']",0.38918874758026295,0,0,5
55,Calcium Regulation in the Cardiac Cell WP536,0.051433626113768255,1.7430527052801854,5.172444611939001,"['RGS16', 'CHRM5', 'ATP1A4', 'ADCY2', 'ATP1B2', 'RGS4', 'GNG3', 'PLN', 'GRK5', 'PRKAR2B', 'GJA9', 'PRKCQ', 'YWHAH']",0.4093124751167333,0,0,13
56,Endochondral Ossification with Skeletal Dysplasias WP4808,0.051884574146043895,2.432926829268293,7.198382734683528,"['HMGCS1', 'ADAMTS1', 'SERPINH1', 'COL10A1', 'SLC38A2', 'FGFR3']",0.4093124751167333,0,0,6
57,Endochondral Ossification WP474,0.051884574146043895,2.432926829268293,7.198382734683528,"['HMGCS1', 'ADAMTS1', 'SERPINH1', 'COL10A1', 'SLC38A2', 'FGFR3']",0.4093124751167333,0,0,6
58,ESC Pluripotency Pathways WP3931,0.05562863186006556,1.883043309150559,5.440219922031959,"['SMAD1', 'JUN', 'WNT2B', 'FZD4', 'EGF', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'FGFR3']",0.4093124751167333,0,0,10
59,IL-1 signaling pathway WP195,0.05920343491028004,2.1631782945736435,6.114819873868452,"['JUN', 'IL1R1', 'IRAK2', 'PELI1', 'TAB2', 'IL1RAP', 'MAP3K14']",0.4093124751167333,0,0,7
60,p53 transcriptional gene network WP4963,0.05920343491028004,2.1631782945736435,6.114819873868452,"['BTG2', 'CDKN1A', 'NOTCH1', 'GADD45A', 'CCNG1', 'PML', 'ICAM1']",0.4093124751167333,0,0,7
61,Oxidative Stress WP408,0.05940344934299779,3.0500988344352806,8.6116581523234,"['NQO1', 'MGST1', 'SOD2', 'JUNB']",0.4093124751167333,0,0,4
62,Tryptophan metabolism WP465,0.05940344934299779,3.0500988344352806,8.6116581523234,"['WARS', 'MAOB', 'AADAT', 'DHCR24']",0.4093124751167333,0,0,4
63,Wnt signaling in kidney disease WP4150,0.05940344934299779,3.0500988344352806,8.6116581523234,"['WNT2B', 'FZD4', 'WNT7B', 'WNT7A']",0.4093124751167333,0,0,4
64,Phytochemical activity on NRF2 transcriptional activation WP3,0.06142746095844177,3.8868055555555556,10.843792199957884,"['NQO1', 'CEBPB', 'GCLM']",0.4093124751167333,0,0,3
65,Transcription factor regulation in adipogenesis WP3599,0.06142746095844177,3.8868055555555556,10.843792199957884,"['CEBPB', 'CEBPD', 'IRS2']",0.4093124751167333,0,0,3
66,Wnt signaling pathway and pluripotency WP399,0.06204926419398421,1.916141235813367,5.326540425872912,"['CCND3', 'JUN', 'WNT2B', 'FZD4', 'WNT7B', 'WNT7A', 'PRKCQ', 'LDLR', 'CD44']",0.4093124751167333,0,0,9
67,Complement Activation WP545,0.06367082946260295,6.473988439306359,17.829550337648044,"['C1S', 'C1R']",0.4093124751167333,0,0,2
68,Farnesoid X receptor pathway WP2879,0.06367082946260295,6.473988439306359,17.829550337648044,"['IRS2', 'FKBP5']",0.4093124751167333,0,0,2
69,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.06367082946260295,6.473988439306359,17.829550337648044,"['SOCS3', 'CHI3L1']",0.4093124751167333,0,0,2
70,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.06367082946260295,6.473988439306359,17.829550337648044,"['LFNG', 'NOTCH1']",0.4093124751167333,0,0,2
71,Lung fibrosis WP3624,0.06864326842014119,2.8803913995107506,7.716085252922109,"['CEBPB', 'EGF', 'HGF', 'ATP11A']",0.4147842296226303,0,0,4
72,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.06864326842014119,2.8803913995107506,7.716085252922109,"['ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.4147842296226303,0,0,4
73,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.06864326842014119,2.8803913995107506,7.716085252922109,"['P4HA2', 'SERPINH1', 'P3H2', 'TNFRSF11B']",0.4147842296226303,0,0,4
74,Apoptosis Modulation and Signaling WP1772,0.06913070493710505,1.9594526325037889,5.235179899394519,"['JUN', 'IL1R1', 'BAG3', 'TNFRSF10B', 'TNFRSF11B', 'MAP3K14', 'TNFRSF1A', 'HSPA1A']",0.4147842296226303,0,0,8
75,Retinoblastoma gene in cancer WP2446,0.06913070493710505,1.9594526325037889,5.235179899394519,"['BARD1', 'CDKN1A', 'CCND3', 'CCNE2', 'RPA3', 'RBP1', 'HMGB2', 'CDC7']",0.4147842296226303,0,0,8
76,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.07065871202574206,2.0644820295983086,5.470658264609885,"['CDKN1A', 'JUN', 'SHC1', 'FZD4', 'TMSB4X', 'FN1', 'PFN2']",0.4183739527839991,0,0,7
77,NAD+ metabolism WP3644,0.07414747687519174,3.5331439393939394,9.192177895869154,"['NT5E', 'NAMPT', 'CD38']",0.4333294103095622,0,0,3
78,Senescence and Autophagy in Cancer WP615,0.07682077742687751,1.8258304195804196,4.685592337483326,"['JUN', 'CDKN1A', 'CEBPB', 'IFI16', 'FN1', 'IRF7', 'COL10A1', 'CXCL14', 'CD44']",0.44236942321007355,0,0,9
79,Exercise-induced Circadian Regulation WP410,0.07766040985243514,2.16182733255904,5.524354485991017,"['CEBPB', 'RBPMS', 'PPP1R3C', 'TAB2', 'ERC2', 'ETV6']",0.44236942321007355,0,0,6
80,Oncostatin M Signaling Pathway WP2374,0.0833420995192542,1.9743680485338726,4.905912611725342,"['SOCS3', 'CEBPB', 'SHC1', 'RPS6', 'OSMR', 'JUNB', 'LDLR']",0.44961171755441814,0,0,7
81,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.08498743161457181,5.178728323699422,12.766869822922102,"['DHCR24', 'DHCR7']",0.44961171755441814,0,0,2
82,Dual hijack model of Vif in HIV infection WP3300,0.08498743161457181,5.178728323699422,12.766869822922102,"['ELOB', 'RUNX1']",0.44961171755441814,0,0,2
83,Nanoparticle triggered regulated necrosis WP2513,0.08498743161457181,5.178728323699422,12.766869822922102,"['TNFRSF1A', 'FTL']",0.44961171755441814,0,0,2
84,IL-4 signaling pathway WP395,0.08505426875195715,2.1032112251624446,5.183292072150292,"['SOCS3', 'CEBPB', 'NFIL3', 'SHC1', 'PIK3CD', 'IRS2']",0.44961171755441814,0,0,6
85,MAPK pathway in congenital thyroid cancer WP4928,0.08792406921064178,3.238425925925926,7.8735256479311815,"['GAREM2', 'JUN', 'SHC1']",0.44961171755441814,0,0,3
86,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.08792406921064178,3.238425925925926,7.8735256479311815,"['JUN', 'ACTN1', 'PRKCQ']",0.44961171755441814,0,0,3
87,Mitochondrial complex III assembly WP4921,0.08792406921064178,3.238425925925926,7.8735256479311815,"['UQCRQ', 'UQCR11', 'UQCR10']",0.44961171755441814,0,0,3
88,Statin inhibition of cholesterol production WP430,0.08792406921064178,3.238425925925926,7.8735256479311815,"['SQLE', 'APOC1', 'LDLR']",0.44961171755441814,0,0,3
89,Neovascularisation processes WP4331,0.0891798595040778,2.59188876013905,6.264854465213877,"['SMAD1', 'KITLG', 'NOTCH1', 'SMAD9']",0.45071072447557525,0,0,4
90,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.09014214489511505,1.9321870361207323,4.649552023589237,"['SFRP4', 'CCND3', 'JUN', 'WNT2B', 'WIF1', 'WNT7B', 'WNT7A']",0.45071072447557525,0,0,7
91,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.10268094004078661,2.9890491452991452,6.803460748487473,"['NQO1', 'JUN', 'GCLM']",0.5077628903115822,0,0,3
92,Inflammatory Response Pathway WP453,0.10807365153783877,4.315221579961464,9.60111913760905,"['FN1', 'TNFRSF1A']",0.51847778633212,0,0,2
93,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.10807365153783877,4.315221579961464,9.60111913760905,"['EGF', 'FN1']",0.51847778633212,0,0,2
94,Interferon type I signaling pathways WP585,0.10945642155900313,1.9449477351916376,4.302669366218964,"['IFNAR2', 'SOCS3', 'RPS6', 'PDCD4', 'PIK3CD', 'IRS2']",0.51847778633212,0,0,6
95,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.10945642155900313,1.9449477351916376,4.302669366218964,"['IL1R1', 'IRAK2', 'IRF7', 'TAB2', 'IL1RAP', 'MAP3K14']",0.51847778633212,0,0,6
96,Oxidative Damage WP3941,0.11229984032391563,2.3558411461076583,5.151241821747045,"['CDKN1A', 'C1S', 'C1R', 'GADD45A']",0.5264055015183545,0,0,4
97,Endometrial cancer WP4155,0.12032918451906367,1.7800045599635204,3.769202531747503,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'FGFR3', 'GADD45G']",0.5582281756039037,0,0,7
98,IL17 signaling pathway WP2112,0.1247557894939857,2.2532117487027055,4.689828482033837,"['CEBPB', 'CEBPD', 'MAP3K14', 'IL17RB']",0.5723029257375176,0,0,4
99,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.12750428967172783,1.8519993363198939,3.814387593983023,"['IFI27L2', 'JUN', 'PLCE1', 'PRKCQ', 'RXRG', 'TNFRSF1A']",0.5723029257375176,0,0,6
100,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.12778453556083624,1.6736640504712907,3.4434127345957917,"['MRAS', 'SHC1', 'EGF', 'HGF', 'RPS6', 'PIK3CD', 'NRG1', 'FGFR3']",0.5723029257375176,0,0,8
101,Dopamine metabolism WP2436,0.1325659765536005,3.698431048720066,7.473326498209042,"['NQO1', 'MAOB']",0.5723029257375176,0,0,2
102,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.1325659765536005,3.698431048720066,7.473326498209042,"['JUN', 'PRKCQ']",0.5723029257375176,0,0,2
103,Nicotine Activity on Dopaminergic Neurons WP1602,0.1325659765536005,3.698431048720066,7.473326498209042,"['CHRNA4', 'ADCY2']",0.5723029257375176,0,0,2
104,Ovarian infertility WP34,0.13480913361817082,2.5900462962962965,5.190181667240584,"['CEBPB', 'INHA', 'SYNE2']",0.5723029257375176,0,0,3
105,Prostaglandin Synthesis and Regulation WP98,0.13480913361817082,2.5900462962962965,5.190181667240584,"['HSD11B1', 'EDNRA', 'S100A6']",0.5723029257375176,0,0,3
106,White fat cell differentiation WP4149,0.13480913361817082,2.5900462962962965,5.190181667240584,"['SREBF1', 'CEBPB', 'CEBPD']",0.5723029257375176,0,0,3
107,COVID-19 adverse outcome pathway WP4891,0.13849643171041987,12.9364896073903,25.574284951810757,['IL7'],0.5739092466671057,0,0,1
108,EV release from cardiac cells and their functional effects WP3297,0.13849643171041987,12.9364896073903,25.574284951810757,['RGS16'],0.5739092466671057,0,0,1
109,Pyrimidine metabolism WP4022,0.14351645648116532,1.6210710128055879,3.146994188221276,"['NT5C', 'POLE4', 'POLD4', 'NME3', 'ENPP3', 'POLR2I', 'POLR2K', 'POLR2L']",0.5739092466671057,0,0,8
110,Myometrial relaxation and contraction pathways WP289,0.145218507120887,1.486906152647975,2.8690088034360643,"['RGS4', 'ACTA2', 'OXTR', 'JUN', 'GNG3', 'GRK5', 'PRKAR2B', 'RGS16', 'PRKCQ', 'ADCY2', 'YWHAH']",0.5739092466671057,0,0,11
111,Notch Signaling Pathway Netpath WP61,0.14688788107468972,1.7675007918910357,3.390217988353811,"['HES6', 'CDKN1A', 'NUMBL', 'NOTCH1', 'HES1', 'HES5']",0.5739092466671057,0,0,6
112,Cell cycle WP179,0.14769581501924517,1.5565034965034965,2.9769692476466223,"['CCND3', 'CDKN1A', 'CCNE2', 'GADD45B', 'GADD45A', 'CDC7', 'ANAPC11', 'GADD45G', 'YWHAH']",0.5739092466671057,0,0,9
113,7-oxo-C and 7beta-HC pathways WP5064,0.15201170294895627,2.427951388888889,4.573769407236442,"['HSD11B1', 'DBP', 'DHCR7']",0.5739092466671057,0,0,3
114,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.15201170294895627,2.427951388888889,4.573769407236442,"['WIF1', 'ZBTB16', 'PML']",0.5739092466671057,0,0,3
115,Non-small cell lung cancer WP4255,0.15504168235938276,1.6499577167019028,3.0756222929573545,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'RXRG', 'GADD45G']",0.5739092466671057,0,0,7
116,VEGFA-VEGFR2 Signaling Pathway WP3888,0.15587722386167266,1.2373337834267766,2.2998157330400852,"['SHC1', 'HSPB1', 'NRARP', 'PLA2G5', 'SHB', 'RPL10A', 'NDRG1', 'APOLD1', 'RPL7', 'ICAM1', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'RPS11', 'TMSB10', 'JUN', 'EGR3', 'RPS6', 'FN1', 'NFATC2', 'BMX', 'SOD2', 'F3', 'RAB11A', 'P4HA2', 'TXNIP', 'MYH9', 'RPL27', 'RPL26', 'ARF6', 'HSPA1A']",0.5739092466671057,0,0,31
117,Cytosolic DNA-sensing pathway WP4655,0.15661622975979234,1.8510109380178985,3.4316944310687543,"['RNF125', 'IL18', 'IRF7', 'POLR2K', 'POLR2L']",0.5739092466671057,0,0,5
118,Eicosanoid Synthesis WP167,0.1581438813038247,3.2358381502890174,5.967694570713954,"['PNPLA3', 'PLA2G5']",0.5739092466671057,0,0,2
119,FOXA2 pathway WP5066,0.1581438813038247,3.2358381502890174,5.967694570713954,"['SREBF1', 'IRS2']",0.5739092466671057,0,0,2
120,Glutathione metabolism WP100,0.1581438813038247,3.2358381502890174,5.967694570713954,"['OPLAH', 'GCLM']",0.5739092466671057,0,0,2
121,Hypertrophy Model WP516,0.1581438813038247,3.2358381502890174,5.967694570713954,"['IL1R1', 'IL18']",0.5739092466671057,0,0,2
122,Kynurenine Pathway and links to Cellular Senescence WP5044,0.1581438813038247,3.2358381502890174,5.967694570713954,"['CDKN1A', 'AADAT']",0.5739092466671057,0,0,2
123,miRNAs involved in DNA damage response WP1545,0.1581438813038247,3.2358381502890174,5.967694570713954,"['CDKN1A', 'CCND3']",0.5739092466671057,0,0,2
124,NOTCH1 regulation of endothelial cell calcification WP3413,0.1581438813038247,3.2358381502890174,5.967694570713954,"['NOTCH1', 'FGFR3']",0.5739092466671057,0,0,2
125,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.1649813118131858,1.4739577808422617,2.655958534273073,"['SNAP25', 'JUN', 'CEBPB', 'CAV3', 'CHRNA4', 'PRKAR2B', 'PAH', 'HES1', 'HES5', 'YWHAH']",0.583487786530416,0,0,10
126,Aryl Hydrocarbon Receptor Netpath WP2586,0.16529583492936767,1.9926909706747482,3.5868805552299774,"['NQO1', 'CDKN1A', 'KLF6', 'PSRC1']",0.583487786530416,0,0,4
127,Type 2 papillary renal cell carcinoma WP4241,0.16529583492936767,1.9926909706747482,3.5868805552299774,"['CDKN1A', 'EGLN3', 'COL21A1', 'ELOB']",0.583487786530416,0,0,4
128,PPAR signaling pathway WP3942,0.16855673635289073,1.7994328435163702,3.203859356483957,"['FABP5', 'SCD', 'DBI', 'ANGPTL4', 'RXRG']",0.583487786530416,0,0,5
129,Wnt signaling WP428,0.16879779489839786,1.5480687366427466,2.754097507132914,"['SFRP4', 'CCND3', 'JUN', 'WNT2B', 'WIF1', 'WNT7B', 'NFATC2', 'WNT7A']",0.583487786530416,0,0,8
130,DNA Mismatch Repair WP531,0.1698597778566322,2.2849264705882355,4.050676560502313,"['POLE4', 'POLD4', 'RPA3']",0.583487786530416,0,0,3
131,Unfolded protein response WP4925,0.1698597778566322,2.2849264705882355,4.050676560502313,"['XBP1', 'TNFRSF10B', 'TXNIP']",0.583487786530416,0,0,3
132,G Protein Signaling Pathways WP35,0.17764826576454304,1.5251660617681297,2.6354102673324094,"['AKAP13', 'GNA14', 'AKAP10', 'GNG3', 'PRKAR2B', 'PRKCQ', 'ADCY2', 'PDE8B']",0.584283633073545,0,0,8
133,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.1797420008920249,1.9187159349384146,3.2929631920048763,"['CDKN1A', 'JUN', 'JUNB', 'TNFRSF1A']",0.584283633073545,0,0,4
134,G1 to S cell cycle control WP45,0.1808400261349777,1.7506427541230325,2.9938485271876094,"['CDKN1A', 'CCND3', 'CCNE2', 'GADD45A', 'RPA3']",0.584283633073545,0,0,5
135,Cancer immunotherapy by PD-1 blockade WP4585,0.1845255392265574,2.876043673731535,4.860420052714804,"['JUN', 'NFATC2']",0.584283633073545,0,0,2
136,Fatty acid transporters WP5061,0.1845255392265574,2.876043673731535,4.860420052714804,"['FABP5', 'DBI']",0.584283633073545,0,0,2
137,Imatinib and Chronic Myeloid Leukemia WP3640,0.1845255392265574,2.876043673731535,4.860420052714804,"['GADD45A', 'PIM1']",0.584283633073545,0,0,2
138,Leptin Insulin Overlap WP3935,0.1845255392265574,2.876043673731535,4.860420052714804,"['SOCS3', 'IRS2']",0.584283633073545,0,0,2
139,TP53 network WP1742,0.1845255392265574,2.876043673731535,4.860420052714804,"['CDKN1A', 'GADD45A']",0.584283633073545,0,0,2
140,Tryptophan catabolism leading to NAD+ production WP4210,0.1845255392265574,2.876043673731535,4.860420052714804,"['AADAT', 'NAMPT']",0.584283633073545,0,0,2
141,Cell migration and invasion through p75NTR WP4561,0.18826917065703117,2.157793209876543,3.603261295279714,"['EFNA1', 'JUN', 'PARD3']",0.584283633073545,0,0,3
142,Heart Development WP1591,0.18826917065703117,2.157793209876543,3.603261295279714,"['SMAD1', 'NOTCH1', 'NFATC2']",0.584283633073545,0,0,3
143,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.18826917065703117,2.157793209876543,3.603261295279714,"['HSPB1', 'NDRG1', 'RAB11A']",0.584283633073545,0,0,3
144,miRNAs involvement in the immune response in sepsis WP4329,0.18826917065703117,2.157793209876543,3.603261295279714,"['IRF7', 'TAB2', 'ICAM1']",0.584283633073545,0,0,3
145,NRF2-ARE regulation WP4357,0.18826917065703117,2.157793209876543,3.603261295279714,"['NQO1', 'CEBPB', 'GCLM']",0.584283633073545,0,0,3
146,Glucocorticoid Receptor Pathway WP2880,0.1934434172279518,1.7044205641714496,2.799971356598151,"['AKAP13', 'JUN', 'GADD45B', 'SPINK13', 'ANGPTL4']",0.5855380345732447,0,0,5
147,Benzene metabolism WP3891,0.20038412738728817,6.467667436489608,10.3968990501937,['NQO1'],0.5855380345732447,0,0,1
148,Composition of Lipid Particles WP3601,0.20038412738728817,6.467667436489608,10.3968990501937,['LDLR'],0.5855380345732447,0,0,1
149,Drug Induction of Bile Acid Pathway WP2289,0.20038412738728817,6.467667436489608,10.3968990501937,['SLC51A'],0.5855380345732447,0,0,1
150,Hypothetical Craniofacial Development Pathway WP3655,0.20038412738728817,6.467667436489608,10.3968990501937,['ARHGAP29'],0.5855380345732447,0,0,1
151,Macrophage markers WP4146,0.20038412738728817,6.467667436489608,10.3968990501937,['F3'],0.5855380345732447,0,0,1
152,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.20038412738728817,6.467667436489608,10.3968990501937,['NRP1'],0.5855380345732447,0,0,1
153,Steroid Biosynthesis WP496,0.20038412738728817,6.467667436489608,10.3968990501937,['HSD17B7'],0.5855380345732447,0,0,1
154,Tamoxifen metabolism WP691,0.20038412738728817,6.467667436489608,10.3968990501937,['CYP3A5'],0.5855380345732447,0,0,1
155,Ferroptosis WP4313,0.20979864361928652,1.786071043273265,2.789141129679063,"['GCLM', 'CP', 'SLC39A14', 'FTL']",0.6051883950556342,0,0,4
156,IL-2 signaling pathway WP49,0.20979864361928652,1.786071043273265,2.789141129679063,"['SOCS3', 'JUN', 'SHC1', 'RPS6']",0.6051883950556342,0,0,4
157,Ebola Virus Pathway on Host WP4217,0.2142352926457938,1.4054680259499537,2.165376997711163,"['BST2', 'SOCS3', 'CAV3', 'ACTN1', 'NEDD4', 'HLA-B', 'IRF7', 'PIK3CD', 'HLA-E']",0.6084023588237378,0,0,9
158,Metapathway biotransformation Phase I and II WP702,0.21496883345105405,1.4399172164015004,2.2135303396607116,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'CHST6', 'HS3ST3A1', 'MGST1', 'CYP3A5', 'CYP3A7']",0.6084023588237378,0,0,8
159,Regulation of toll-like receptor signaling pathway WP1449,0.21496883345105405,1.4399172164015004,2.2135303396607116,"['IFNAR2', 'JUN', 'IRAK2', 'SFTPD', 'IRF7', 'PELI1', 'PIK3CD', 'TAB2']",0.6084023588237378,0,0,8
160,Melanoma WP4685,0.22377944715909442,1.5239461638313863,2.2814911505388955,"['GRM3', 'CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD', 'GADD45G']",0.6256381242855579,0,0,6
161,PI3K-Akt signaling pathway WP4172,0.22383941779994404,1.2531818181818182,1.8757955906479828,"['IFNAR2', 'CDKN1A', 'EGF', 'HGF', 'RPS6', 'LAMA3', 'FN1', 'PIK3CD', 'OSMR', 'EFNA1', 'KITLG', 'CCND3', 'GNG3', 'CCNE2', 'COL4A1', 'IL7', 'FGFR3']",0.6256381242855579,0,0,17
162,Oxidation by Cytochrome P450 WP43,0.22644474001951587,1.9416666666666667,2.883868838158818,"['CYP39A1', 'CYP3A5', 'CYP3A7']",0.6290131667208774,0,0,3
163,Neural Crest Differentiation WP2064,0.2357160163043873,1.4945054945054945,2.1597510178136594,"['SMAD1', 'NOTCH1', 'HES1', 'FGFR3', 'HES5', 'GFAP']",0.6394909515523038,0,0,6
164,Proteasome Degradation WP183,0.2357160163043873,1.4945054945054945,2.1597510178136594,"['PSMB6', 'NEDD4', 'HLA-B', 'PSMB10', 'HLA-E', 'PSMB9']",0.6394909515523038,0,0,6
165,Airway smooth muscle cell contraction WP4962,0.23874328857952679,2.352706253284288,3.3699374113966836,"['PPP1R14A', 'CD38']",0.6394909515523038,0,0,2
166,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.23874328857952679,2.352706253284288,3.3699374113966836,"['EGF', 'HSPB1']",0.6394909515523038,0,0,2
167,miRNA targets in ECM and membrane receptors WP2911,0.23874328857952679,2.352706253284288,3.3699374113966836,"['COL4A1', 'FN1']",0.6394909515523038,0,0,2
168,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.23874328857952679,2.352706253284288,3.3699374113966836,"['NQO1', 'FN1']",0.6394909515523038,0,0,2
169,Oxysterols derived from cholesterol WP4545,0.2460540099105814,1.8490410052910053,2.5927330907090376,"['CYP39A1', 'DBP', 'DHCR7']",0.6489085017419967,0,0,3
170,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2460540099105814,1.8490410052910053,2.5927330907090376,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.6489085017419967,0,0,3
171,Cardiac Hypertrophic Response WP2795,0.24658523066195873,1.5415423710087284,2.158232668969155,"['EGF', 'NFATC2', 'NRG1', 'MAP3K14', 'TNFRSF1A']",0.6489085017419967,0,0,5
172,Blood Clotting Cascade WP272,0.25783076663826443,4.31139337952271,5.843886143337087,['F3'],0.6518193538607809,0,0,1
173,Cells and molecules involved in local acute inflammatory response  WP4493,0.25783076663826443,4.31139337952271,5.843886143337087,['ICAM1'],0.6518193538607809,0,0,1
174,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.25783076663826443,4.31139337952271,5.843886143337087,['OPLAH'],0.6518193538607809,0,0,1
175,Irinotecan pathway WP229,0.25783076663826443,4.31139337952271,5.843886143337087,['CYP3A5'],0.6518193538607809,0,0,1
176,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.25783076663826443,4.31139337952271,5.843886143337087,['CDKN1A'],0.6518193538607809,0,0,1
177,Osteoblast Signaling WP322,0.25783076663826443,4.31139337952271,5.843886143337087,['TNFRSF11B'],0.6518193538607809,0,0,1
178,The alternative pathway of fetal androgen synthesis WP4524,0.25783076663826443,4.31139337952271,5.843886143337087,['HSD17B6'],0.6518193538607809,0,0,1
179,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.260142009427424,1.4388953413343657,1.9375123006453117,"['SREBF1', 'SQLE', 'HMGCS1', 'SCD', 'DBI', 'LDLR']",0.6539882918566525,0,0,6
180,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.26617592543917534,2.1564547206165705,2.8542787563119174,"['ICAM1', 'TNFRSF1A']",0.6654398135979384,0,0,2
181,Pancreatic adenocarcinoma pathway WP4263,0.26932356986488604,1.3736081747709654,1.8019565659373615,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'RALGDS', 'GADD45G']",0.6695889858519266,0,0,7
182,TGF-beta Receptor Signaling WP560,0.27345465250052986,1.5690157660030197,2.034416399178204,"['SMAD1', 'JUN', 'EGF', 'SMAD9']",0.6761241407980134,0,0,4
183,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.285193182631959,1.3872573419611747,1.7404371001943881,"['CDKN1A', 'JUN', 'GADD45B', 'GADD45A', 'RALGDS', 'GADD45G']",0.6863706475441733,0,0,6
184,Prolactin Signaling Pathway WP2037,0.285193182631959,1.3872573419611747,1.7404371001943881,"['SOCS3', 'JUN', 'SHC1', 'RPS6KA2', 'RPS6', 'IRS2']",0.6863706475441733,0,0,6
185,Focal Adhesion WP306,0.28775986186177555,1.2339738234475077,1.5370735299258067,"['MYL5', 'JUN', 'CCND3', 'CAV3', 'COL4A1', 'SHC1', 'EGF', 'ACTN1', 'HGF', 'LAMA3', 'FN1', 'PIK3CD']",0.6863706475441733,0,0,12
186,Glycogen Synthesis and Degradation WP500,0.28987871493886547,1.5227319201145115,1.885587771749337,"['HKDC1', 'PYGM', 'PYGL', 'GYG2']",0.6863706475441733,0,0,4
187,IL-3 signaling pathway WP286,0.28987871493886547,1.5227319201145115,1.885587771749337,"['JUN', 'SHC1', 'PIK3CD', 'ENPP3']",0.6863706475441733,0,0,4
188,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.28987871493886547,1.5227319201145115,1.885587771749337,"['JUN', 'NFATC2', 'PRKCQ', 'MAP3K14']",0.6863706475441733,0,0,4
189,TNF-alpha signaling pathway WP231,0.2922516585495347,1.33296853625171,1.6397379199043547,"['JUN', 'OTUD7B', 'TAB2', 'PYGL', 'RFFL', 'MAP3K14', 'TNFRSF1A']",0.6863706475441733,0,0,7
190,Pregnane X receptor pathway WP2876,0.2935992872561346,1.990395731436194,2.4393084100651956,"['CYP3A5', 'CYP3A7']",0.6863706475441733,0,0,2
191,Purinergic signaling WP4900,0.2935992872561346,1.990395731436194,2.4393084100651956,"['P2RY12', 'P2RY14']",0.6863706475441733,0,0,2
192,Insulin Signaling WP481,0.2961939288694961,1.2241469816272965,1.4894696684341842,"['SOCS3', 'SNAP25', 'XBP1', 'JUN', 'SHC1', 'RPS6KA2', 'PIK3CD', 'IRS2', 'PRKCQ', 'MAP3K6', 'MAP3K14', 'ARF6']",0.6863706475441733,0,0,12
193,Circadian rhythm related genes WP3594,0.30385881901799505,1.2283274250725105,1.4631739207504564,"['SREBF1', 'JUN', 'EGR3', 'DBP', 'NFIL3', 'NOCT', 'NAMPT', 'ID3', 'CARTPT', 'RPS27A', 'PML']",0.6863706475441733,0,0,11
194,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.30452496381919164,1.1780792650357867,1.4007388522824593,"['IFNAR2', 'SREBF1', 'CDKN1A', 'EGF', 'HGF', 'RPS6', 'LAMA3', 'FN1', 'PIK3CD', 'IRS2', 'OSMR', 'EFNA1', 'KITLG', 'GNG3', 'COL4A1', 'FGFR3']",0.6863706475441733,0,0,16
195,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.31115469355335856,3.233256351039261,3.7747138959876056,['COX8A'],0.6863706475441733,0,0,1
196,Bile acids synthesis and enterohepatic circulation  WP4389,0.31115469355335856,3.233256351039261,3.7747138959876056,['LDLR'],0.6863706475441733,0,0,1
197,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.31115469355335856,3.233256351039261,3.7747138959876056,['HSD11B1'],0.6863706475441733,0,0,1
198,Cytokines and Inflammatory Response WP530,0.31115469355335856,3.233256351039261,3.7747138959876056,['IL7'],0.6863706475441733,0,0,1
199,Estrogen metabolism WP697,0.31115469355335856,3.233256351039261,3.7747138959876056,['NQO1'],0.6863706475441733,0,0,1
200,miR-517 relationship with ARCN1 and USP1 WP3596,0.31115469355335856,3.233256351039261,3.7747138959876056,['CDKN1A'],0.6863706475441733,0,0,1
201,Role of Osx and miRNAs in tooth development WP3971,0.31115469355335856,3.233256351039261,3.7747138959876056,['NOTCH1'],0.6863706475441733,0,0,1
202,SARS-CoV-2 and COVID-19 Pathway WP4846,0.31115469355335856,3.233256351039261,3.7747138959876056,['NRP1'],0.6863706475441733,0,0,1
203,Serotonin Transporter Activity WP1455,0.31115469355335856,3.233256351039261,3.7747138959876056,['IL1R1'],0.6863706475441733,0,0,1
204,Vitamin D Metabolism WP1531,0.31115469355335856,3.233256351039261,3.7747138959876056,['DHCR7'],0.6863706475441733,0,0,1
205,Apoptosis Modulation by HSP70 WP384,0.3208733342435084,1.848059454995871,2.1007055028887005,"['TNFRSF1A', 'HSPA1A']",0.6975507266163226,0,0,2
206,Cardiac Progenitor Differentiation WP2406,0.3208733342435084,1.848059454995871,2.1007055028887005,"['NOTCH1', 'NRG1']",0.6975507266163226,0,0,2
207,Gastric Cancer Network 1 WP2361,0.3208733342435084,1.848059454995871,2.1007055028887005,"['NOTCH1', 'GATD3A']",0.6975507266163226,0,0,2
208,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.32307782236612764,1.4378782026522468,1.6246040117749345,"['RPS6KA2', 'RPS6', 'PIM1', 'PDCD4']",0.6989664426190261,0,0,4
209,Alpha 6 Beta 4 signaling pathway WP244,0.3262969877342303,1.552638888888889,1.738873742368866,"['SHC1', 'LAMA3', 'IRS2']",0.699207830859065,0,0,3
210,Bladder cancer WP2828,0.3262969877342303,1.552638888888889,1.738873742368866,"['CDKN1A', 'EGF', 'FGFR3']",0.699207830859065,0,0,3
211,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.33978280182130843,1.3988913594939087,1.5100314366111793,"['SMAD1', 'JUN', 'EGF', 'SMAD9']",0.7130703825352063,0,0,4
212,ATM Signaling Pathway WP2516,0.3464900405205548,1.4927884615384615,1.5822082874805299,"['CDKN1A', 'JUN', 'GADD45A']",0.7130703825352063,0,0,3
213,Canonical and non-canonical Notch signaling WP3845,0.34787814793988664,1.7247013487475915,1.8211173457047,"['NOTCH1', 'HES1']",0.7130703825352063,0,0,2
214,Monoamine Transport WP727,0.34787814793988664,1.7247013487475915,1.8211173457047,"['IL1R1', 'TNFRSF11B']",0.7130703825352063,0,0,2
215,NAD+ biosynthetic pathways WP3645,0.34787814793988664,1.7247013487475915,1.8211173457047,"['NAMPT', 'CD38']",0.7130703825352063,0,0,2
216,Sleep regulation WP3591,0.34787814793988664,1.7247013487475915,1.8211173457047,"['OXTR', 'IL18']",0.7130703825352063,0,0,2
217,Ectoderm Differentiation WP2858,0.3512792648118801,1.2011030206906494,1.2565624460246787,"['CLDN11', 'TRPM2', 'TSC22D1', 'FZD4', 'ZBTB16', 'PIM1', 'HMGB2', 'TNFRSF11B', 'KIFC3']",0.7130703825352063,0,0,9
218,Biogenic Amine Synthesis WP550,0.3606514596252027,2.5863741339491915,2.637696261539042,['PAH'],0.7130703825352063,0,0,1
219,Caloric restriction and aging WP4191,0.3606514596252027,2.5863741339491915,2.637696261539042,['NAMPT'],0.7130703825352063,0,0,1
220,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.3606514596252027,2.5863741339491915,2.637696261539042,['CEBPB'],0.7130703825352063,0,0,1
221,Genes targeted by miRNAs in adipocytes WP1992,0.3606514596252027,2.5863741339491915,2.637696261539042,['TMSB4X'],0.7130703825352063,0,0,1
222,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3606514596252027,2.5863741339491915,2.637696261539042,['RPS6'],0.7130703825352063,0,0,1
223,Insulin signaling in adipocytes (normal condition) WP3634,0.3606514596252027,2.5863741339491915,2.637696261539042,['RPS6'],0.7130703825352063,0,0,1
224,LDLRAD4 and what we know about it WP4904,0.3606514596252027,2.5863741339491915,2.637696261539042,['NEDD4'],0.7130703825352063,0,0,1
225,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.3606514596252027,2.5863741339491915,2.637696261539042,['LDLR'],0.7130703825352063,0,0,1
226,Platelet-mediated interactions with vascular and circulating cells WP4462,0.3606514596252027,2.5863741339491915,2.637696261539042,['ICAM1'],0.7130703825352063,0,0,1
227,CAMKK2  Pathway WP4874,0.3666227256635985,1.4373713991769548,1.4422900196306958,"['FIS1', 'NFATC2', 'ICAM1']",0.7130703825352063,0,0,3
228,DNA Replication WP466,0.3666227256635985,1.4373713991769548,1.4422900196306958,"['POLD4', 'RPA3', 'CDC7']",0.7130703825352063,0,0,3
229,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.37451176881811904,1.6167630057803468,1.5878747670146534,"['BCL6', 'H2AFJ']",0.7130703825352063,0,0,2
230,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.37451176881811904,1.6167630057803468,1.5878747670146534,"['UGCG', 'GALNT16']",0.7130703825352063,0,0,2
231,miRNA regulation of p53 pathway in prostate cancer WP3982,0.37451176881811904,1.6167630057803468,1.5878747670146534,"['TNFRSF10B', 'CYS1']",0.7130703825352063,0,0,2
232,Striated Muscle Contraction Pathway WP383,0.37451176881811904,1.6167630057803468,1.5878747670146534,"['ACTA2', 'ACTN2']",0.7130703825352063,0,0,2
233,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.37451176881811904,1.6167630057803468,1.5878747670146534,"['IFNAR2', 'IRF7']",0.7130703825352063,0,0,2
234,MAPK Signaling Pathway WP382,0.37453210318636765,1.1225881299356835,1.1024688325752041,"['JUN', 'PTPRR', 'IL1R1', 'GADD45A', 'EGF', 'HSPB1', 'TNFRSF1A', 'MRAS', 'TAB2', 'PTPN7', 'MAP3K6', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.7130703825352063,0,0,15
235,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.37555040146854196,1.2684818707065193,1.242303692591858,"['TUBB6', 'TUBB2B', 'RNF19A', 'HSPA1B', 'HSPA1A']",0.7130703825352063,0,0,5
236,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.37555040146854196,1.2684818707065193,1.242303692591858,"['CCND3', 'JUN', 'RPS6', 'ADCY2', 'RALGDS']",0.7130703825352063,0,0,5
237,Toll-like Receptor Signaling Pathway WP75,0.37555040146854196,1.2684818707065193,1.242303692591858,"['IFNAR2', 'JUN', 'IRF7', 'PIK3CD', 'TAB2']",0.7130703825352063,0,0,5
238,RANKL/RANK signaling pathway WP2018,0.38992827465413177,1.2936268829663964,1.218328054670661,"['JUN', 'TNFRSF11B', 'TAB2', 'ICAM1']",0.7300460846200284,0,0,4
239,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.3928950726089304,1.1531191580696531,1.0772585546769233,"['SREBF1', 'SHC1', 'SCD', 'RPS6KA2', 'TRIP10', 'PIK3CD', 'IRS2', 'MAP3K6', 'MAP3K14']",0.7300460846200284,0,0,9
240,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.40068823985810675,1.5215232913974839,1.3915420074294382,"['CEBPB', 'ATP2C2']",0.7300460846200284,0,0,2
241,TYROBP causal network in microglia WP3945,0.40068823985810675,1.5215232913974839,1.3915420074294382,"['IL18', 'IL13RA1']",0.7300460846200284,0,0,2
242,Zinc homeostasis WP3529,0.40068823985810675,1.5215232913974839,1.3915420074294382,"['SLC39A11', 'SLC39A14']",0.7300460846200284,0,0,2
243,Regulation of Actin Cytoskeleton WP51,0.4033460300368431,1.141711229946524,1.0366286422547135,"['MRAS', 'EGF', 'ACTN1', 'TMSB4X', 'CHRM5', 'FN1', 'PIP4K2A', 'PIK3CD', 'FGFR3']",0.7300460846200284,0,0,9
244,Hepatitis C and Hepatocellular Carcinoma WP3646,0.4065135213899401,1.3380028735632183,1.2043873478065983,"['CDKN1A', 'JUN', 'CD44']",0.7300460846200284,0,0,3
245,IL-5 signaling pathway WP127,0.4065135213899401,1.3380028735632183,1.2043873478065983,"['JUN', 'SHC1', 'RPS6']",0.7300460846200284,0,0,3
246,Glial Cell Differentiation WP2276,0.406595452294638,2.1551193225558123,1.9394706750605257,['GAP43'],0.7300460846200284,0,0,1
247,Mevalonate pathway WP3963,0.406595452294638,2.1551193225558123,1.9394706750605257,['HMGCS1'],0.7300460846200284,0,0,1
248,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.406595452294638,2.1551193225558123,1.9394706750605257,['HES1'],0.7300460846200284,0,0,1
249,Osteoclast Signaling WP12,0.406595452294638,2.1551193225558123,1.9394706750605257,['TNFRSF11B'],0.7300460846200284,0,0,1
250,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.406595452294638,2.1551193225558123,1.9394706750605257,['JUN'],0.7300460846200284,0,0,1
251,Chemokine signaling pathway WP3929,0.40720348275472695,1.1500711421549605,1.0332725170941985,"['GNG3', 'GRK5', 'SHC1', 'PARD3', 'PIK3CD', 'PRKX', 'ADCY2', 'CXCL14']",0.7300460846200284,0,0,8
252,EGF/EGFR signaling pathway WP437,0.41471361283344177,1.1119669976635513,0.9787167526519419,"['JUN', 'PTPRR', 'PLSCR1', 'SHC1', 'EGF', 'RPS6KA2', 'LIMK2', 'NEDD4', 'PLCE1', 'RALGDS', 'ARF6']",0.7405600229168603,0,0,11
253,T-cell receptor (TCR) signaling pathway WP69,0.41923740165239753,1.197688407665206,1.0411720054876006,"['JUN', 'SHC1', 'NFATC2', 'PRKCQ', 'MAP3K14']",0.7456791728995212,0,0,5
254,Phosphoinositides metabolism WP4971,0.4261850026297282,1.293287037037037,1.103020909474539,"['PIK3CD', 'PIP4K2A', 'PLCE1']",0.7523257962579111,0,0,3
255,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.42633583819492027,1.4368657675016057,1.2249681420291298,"['CDKN1A', 'FGFR3']",0.7523257962579111,0,0,2
256,Biomarkers for urea cycle disorders WP4583,0.4492414082382967,1.8470801715605412,1.4780240928698354,['GPT'],0.7523257962579111,0,0,1
257,Cancer immunotherapy by CTLA4 blockade WP4582,0.4492414082382967,1.8470801715605412,1.4780240928698354,['PIK3CD'],0.7523257962579111,0,0,1
258,Estrogen Receptor Pathway WP2881,0.4492414082382967,1.8470801715605412,1.4780240928698354,['JUN'],0.7523257962579111,0,0,1
259,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.4492414082382967,1.8470801715605412,1.4780240928698354,['PRKCQ'],0.7523257962579111,0,0,1
260,Galanin receptor pathway WP4970,0.4492414082382967,1.8470801715605412,1.4780240928698354,['CDKN1A'],0.7523257962579111,0,0,1
261,"GPCRs, Class B Secretin-like WP334",0.4492414082382967,1.8470801715605412,1.4780240928698354,['ADGRG2'],0.7523257962579111,0,0,1
262,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.4492414082382967,1.8470801715605412,1.4780240928698354,['ELOB'],0.7523257962579111,0,0,1
263,Major receptors targeted by epinephrine and norepinephrine WP4589,0.4492414082382967,1.8470801715605412,1.4780240928698354,['ADCY2'],0.7523257962579111,0,0,1
264,RAS and bradykinin pathways in COVID-19 WP4969,0.4492414082382967,1.8470801715605412,1.4780240928698354,['SERPING1'],0.7523257962579111,0,0,1
265,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4492414082382967,1.8470801715605412,1.4780240928698354,['ANAPC11'],0.7523257962579111,0,0,1
266,Thiamine metabolic pathways WP4297,0.4492414082382967,1.8470801715605412,1.4780240928698354,['SLC19A3'],0.7523257962579111,0,0,1
267,Trans-sulfuration pathway WP2333,0.4492414082382967,1.8470801715605412,1.4780240928698354,['GCLM'],0.7523257962579111,0,0,1
268,EPO Receptor Signaling WP581,0.45139547775474664,1.3611195619105567,1.082650061107699,"['SHC1', 'IRS2']",0.7523257962579111,0,0,2
269,Photodynamic therapy-induced unfolded protein response WP3613,0.45139547775474664,1.3611195619105567,1.082650061107699,"['XBP1', 'WARS']",0.7523257962579111,0,0,2
270,TLR4 Signaling and Tolerance WP3851,0.45139547775474664,1.3611195619105567,1.082650061107699,"['IRF7', 'TAB2']",0.7523257962579111,0,0,2
271,Kit receptor signaling pathway WP304,0.45578704902686873,1.1756030759507006,0.923706106755791,"['KITLG', 'SHC1', 'RPS6', 'JUNB']",0.7568419633287488,0,0,4
272,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4647927349632252,1.2122395833333333,0.9287739693316249,"['IFNAR2', 'CXCL17', 'IRF7']",0.7689585688729829,0,0,3
273,Ras signaling WP4223,0.46854414532433114,1.0687869465847615,0.8102740555666212,"['GNG3', 'MRAS', 'SHC1', 'RASA4', 'PLCE1', 'PIK3CD', 'PLA2G5', 'RALGDS', 'FGFR3', 'ARF6']",0.7723255142708755,0,0,10
274,Mitochondrial complex I assembly model OXPHOS system WP4324,0.4719055124735615,1.1493755632805458,0.8631540364034462,"['NDUFA7', 'NDUFA2', 'NDUFA1', 'TMEM70']",0.7736240153386768,0,0,4
275,"GPCRs, Other WP117",0.47581926743850134,1.2929479768786127,0.960294684462404,"['EDNRA', 'GPR135']",0.7736240153386768,0,0,2
276,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.47581926743850134,1.2929479768786127,0.960294684462404,"['RAB13', 'NDRG1']",0.7736240153386768,0,0,2
277,Integrated breast cancer pathway WP1984,0.47620856055291877,1.0677166869827421,0.7921383355845069,"['BARD1', 'SMAD1', 'ITPKC', 'JUN', 'RASGEF1A', 'GADD45A', 'FAU', 'PML', 'FOSL2']",0.7736240153386768,0,0,9
278,IL-6 signaling pathway WP364,0.4836651269832027,1.1753998316498318,0.853766358016052,"['SOCS3', 'SHC1', 'JUNB']",0.777284871273106,0,0,3
279,15q13.3 copy number variation syndrome WP4942,0.48882581904508665,1.6160508083140877,1.1566868327947177,['SERPINH1'],0.777284871273106,0,0,1
280,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.48882581904508665,1.6160508083140877,1.1566868327947177,['GRM3'],0.777284871273106,0,0,1
281,"NAD metabolism, sirtuins and aging WP3630",0.48882581904508665,1.6160508083140877,1.1566868327947177,['NAMPT'],0.777284871273106,0,0,1
282,Neuroinflammation WP4919,0.48882581904508665,1.6160508083140877,1.1566868327947177,['JUN'],0.777284871273106,0,0,1
283,NLR Proteins WP288,0.48882581904508665,1.6160508083140877,1.1566868327947177,['ERBIN'],0.777284871273106,0,0,1
284,TGF-beta Signaling Pathway WP366,0.49558965746743583,1.0554275260744577,0.7409175093493487,"['JUN', 'CDKN1A', 'KLF6', 'SHC1', 'LIMK2', 'FN1', 'JUNB', 'PML']",0.7852653023251625,0,0,8
285,Interleukin-11 Signaling Pathway WP2332,0.5022131010866626,1.1407271241830066,0.7856538423199456,"['SOCS3', 'RPS6', 'ICAM1']",0.7894542380044748,0,0,3
286,Netrin-UNC5B signaling pathway WP4747,0.5022131010866626,1.1407271241830066,0.7856538423199456,"['JUN', 'UNC5B', 'ICAM1']",0.7894542380044748,0,0,3
287,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5035798857787703,1.100268731047065,0.7547985632954746,"['CDKN1A', 'NOTCH1', 'PLCE1', 'MYH9']",0.7894542380044748,0,0,4
288,ErbB signaling pathway WP673,0.5052507123228639,1.062574578779056,0.7254202098812911,"['CDKN1A', 'JUN', 'SHC1', 'EGF', 'PIK3CD', 'NRG1']",0.7894542380044748,0,0,6
289,16p11.2 distal deletion syndrome WP4950,0.5226160349642641,1.1751970572779822,0.7625950579835391,"['PLN', 'NFATC2']",0.7909889848216816,0,0,2
290,Nanoparticle-mediated activation of receptor signaling WP2643,0.5226160349642641,1.1751970572779822,0.7625950579835391,"['FN1', 'PIK3CD']",0.7909889848216816,0,0,2
291,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.5255682365815173,1.4363613035668463,0.9239756713585352,['NOTCH1'],0.7909889848216816,0,0,1
292,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.5255682365815173,1.4363613035668463,0.9239756713585352,['SMAD1'],0.7909889848216816,0,0,1
293,Ganglio Sphingolipid Metabolism WP1423,0.5255682365815173,1.4363613035668463,0.9239756713585352,['ST8SIA1'],0.7909889848216816,0,0,1
294,Homologous recombination WP186,0.5255682365815173,1.4363613035668463,0.9239756713585352,['POLD4'],0.7909889848216816,0,0,1
295,Matrix Metalloproteinases WP129,0.5255682365815173,1.4363613035668463,0.9239756713585352,['MMP15'],0.7909889848216816,0,0,1
296,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.5255682365815173,1.4363613035668463,0.9239756713585352,['HMGCS1'],0.7909889848216816,0,0,1
297,Monoamine GPCRs WP58,0.5255682365815173,1.4363613035668463,0.9239756713585352,['CHRM5'],0.7909889848216816,0,0,1
298,Osteopontin Signaling WP1434,0.5255682365815173,1.4363613035668463,0.9239756713585352,['MAP3K14'],0.7909889848216816,0,0,1
299,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5255682365815173,1.4363613035668463,0.9239756713585352,['SAMHD1'],0.7909889848216816,0,0,1
300,Apoptosis WP254,0.5343880837068755,1.0551706198122355,0.6612046840085756,"['JUN', 'IRF7', 'TNFRSF10B', 'TNFRSF1A']",0.7989190620202458,0,0,4
301,MET in type 1 papillary renal cell carcinoma WP4205,0.5343880837068755,1.0551706198122355,0.6612046840085756,"['CDKN1A', 'JUN', 'HGF', 'PIK3CD']",0.7989190620202458,0,0,4
302,Phosphodiesterases in neuronal function WP4222,0.5382449651016532,1.0771604938271604,0.6672379087859308,"['PDE5A', 'ADCY2', 'PDE8B']",0.8020206433633905,0,0,3
303,Resistin as a regulator of inflammation WP4481,0.5449381351883905,1.124001005277708,0.682361906982887,"['PIK3CD', 'PLCE1']",0.809314062160976,0,0,2
304,Modulators of TCR signaling and T cell activation WP5072,0.5556909393087838,1.0479542042042043,0.6157181610186884,"['ELOB', 'PRKCQ', 'MAP3K14']",0.8150570168689327,0,0,3
305,Alanine and aspartate metabolism WP106,0.5596724849166671,1.292609699769053,0.7502352128897389,['GPT'],0.8150570168689327,0,0,1
306,Biomarkers for pyrimidine metabolism disorders WP4584,0.5596724849166671,1.292609699769053,0.7502352128897389,['NT5C'],0.8150570168689327,0,0,1
307,GPR40 Pathway WP3958,0.5596724849166671,1.292609699769053,0.7502352128897389,['PLCE1'],0.8150570168689327,0,0,1
308,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.5596724849166671,1.292609699769053,0.7502352128897389,['MAP3K14'],0.8150570168689327,0,0,1
309,RalA downstream regulated genes WP2290,0.5596724849166671,1.292609699769053,0.7502352128897389,['YBX3'],0.8150570168689327,0,0,1
310,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5665206273104295,1.0770712909441233,0.6120369154495916,"['PIK3CD', 'PRKCQ']",0.8223686525473977,0,0,2
311,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5727363078231986,1.0202850877192982,0.5686353491400348,"['ADCY2', 'SYNE3', 'SYNE2']",0.8235514537077246,0,0,3
312,Base Excision Repair WP4752,0.5873544953778138,1.0338959537572254,0.5501636741501755,"['POLE4', 'POLD4']",0.8235514537077246,0,0,2
313,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5873544953778138,1.0338959537572254,0.5501636741501755,"['IFNAR2', 'JUN']",0.8235514537077246,0,0,2
314,Lipid Metabolism Pathway WP3965,0.5873544953778138,1.0338959537572254,0.5501636741501755,"['PRKAR2B', 'HILPDA']",0.8235514537077246,0,0,2
315,Neural Crest Cell Migration during Development WP4564,0.5873544953778138,1.0338959537572254,0.5501636741501755,"['JUN', 'PIK3CD']",0.8235514537077246,0,0,2
316,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.5893688113644154,0.9940349002849003,0.5255493591194473,"['PPP1R14A', 'XBP1', 'PPP1R3C']",0.8235514537077246,0,0,3
317,Nucleotide Excision Repair WP4753,0.5893688113644154,0.9940349002849003,0.5255493591194473,"['POLE4', 'POLD4', 'RPA3']",0.8235514537077246,0,0,3
318,Gastrin signaling pathway WP4659,0.5898031982297348,0.9689895470383275,0.5115938840754917,"['JUN', 'CDKN1A', 'SHC1', 'RPS6', 'PRKCQ', 'CD44']",0.8235514537077246,0,0,6
319,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5913277858390864,1.1749947512072223,0.6173243660981325,['CD38'],0.8235514537077246,0,0,1
320,Cori Cycle WP1946,0.5913277858390864,1.1749947512072223,0.6173243660981325,['GPT'],0.8235514537077246,0,0,1
321,Cysteine and methionine catabolism WP4504,0.5913277858390864,1.1749947512072223,0.6173243660981325,['SQOR'],0.8235514537077246,0,0,1
322,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5913277858390864,1.1749947512072223,0.6173243660981325,['SYTL4'],0.8235514537077246,0,0,1
323,Pyrimidine metabolism and related diseases WP4225,0.5913277858390864,1.1749947512072223,0.6173243660981325,['NT5C'],0.8235514537077246,0,0,1
324,MECP2 and Associated Rett Syndrome WP3584,0.5929570466695617,0.9751852904523493,0.5096643226044237,"['CEBPD', 'BCL6', 'RPS6', 'FKBP5']",0.8235514537077246,0,0,4
325,Allograft Rejection WP2328,0.6074358271912755,0.9940417963539351,0.4955385269864548,"['HLA-B', 'HLA-E']",0.8350355971663238,0,0,2
326,Head and Neck Squamous Cell Carcinoma WP4674,0.62054934226033,0.9395554619193089,0.4483090364819587,"['CDKN1A', 'NOTCH1', 'RPS6', 'FGFR3']",0.8350355971663238,0,0,4
327,Canonical and non-canonical TGF-B signaling WP3874,0.6207098039754149,1.0769822940723635,0.5136038208690213,['LOXL2'],0.8350355971663238,0,0,1
328,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.6207098039754149,1.0769822940723635,0.5136038208690213,['GADD45G'],0.8350355971663238,0,0,1
329,Omega-3/Omega-6 FA synthesis WP4723,0.6207098039754149,1.0769822940723635,0.5136038208690213,['PLA2G5'],0.8350355971663238,0,0,1
330,Omega-9 FA synthesis WP4724,0.6207098039754149,1.0769822940723635,0.5136038208690213,['SCD'],0.8350355971663238,0,0,1
331,PPAR-alpha pathway WP2878,0.6207098039754149,1.0769822940723635,0.5136038208690213,['DBI'],0.8350355971663238,0,0,1
332,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6207098039754149,1.0769822940723635,0.5136038208690213,['BCL2L14'],0.8350355971663238,0,0,1
333,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.6207098039754149,1.0769822940723635,0.5136038208690213,['F3'],0.8350355971663238,0,0,1
334,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.6207098039754149,1.0769822940723635,0.5136038208690213,['FN1'],0.8350355971663238,0,0,1
335,22q11.2 copy number variation syndrome WP4657,0.6216376112238188,0.936060392077743,0.4450012145366883,"['ACTA2', 'SREBF1', 'AIFM3', 'THAP7', 'HES1']",0.8350355971663238,0,0,5
336,PDGFR-beta pathway WP3972,0.6267651293151479,0.9571397987582959,0.44715982825495076,"['JUN', 'SHC1']",0.839417583904216,0,0,2
337,Neural Crest Cell Migration in Cancer WP4565,0.6453467136538362,0.9228736581337738,0.40418872983461296,"['JUN', 'PIK3CD']",0.8576227280898225,0,0,2
338,ERK Pathway in Huntington's Disease WP3853,0.647981616778977,0.9940486764967135,0.43131071487617884,['EGF'],0.8576227280898225,0,0,1
339,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.647981616778977,0.9940486764967135,0.43131071487617884,['SFRP4'],0.8576227280898225,0,0,1
340,SARS coronavirus and innate immunity WP4912,0.647981616778977,0.9940486764967135,0.43131071487617884,['IFNAR2'],0.8576227280898225,0,0,1
341,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6631881496828145,0.8909706996212876,0.36591858688322076,"['JUN', 'HGF']",0.8700719164934885,0,0,2
342,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6631881496828145,0.8909706996212876,0.36591858688322076,"['JUN', 'MAP3K14']",0.8700719164934885,0,0,2
343,Vitamin D-sensitive calcium signaling in depression WP4698,0.6631881496828145,0.8909706996212876,0.36591858688322076,"['CALB1', 'PVALB']",0.8700719164934885,0,0,2
344,Constitutive Androstane Receptor Pathway WP2875,0.6732946156709023,0.9229627185747278,0.3650984672989078,['CYP3A5'],0.8731486370371933,0,0,1
345,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6732946156709023,0.9229627185747278,0.3650984672989078,['PLA2G5'],0.8731486370371933,0,0,1
346,Overview of interferons-mediated signaling pathway WP4558,0.6732946156709023,0.9229627185747278,0.3650984672989078,['IFNAR2'],0.8731486370371933,0,0,1
347,Triacylglyceride synthesis WP325,0.6732946156709023,0.9229627185747278,0.3650984672989078,['MOGAT1'],0.8731486370371933,0,0,1
348,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.6800838034819728,0.8610339506172839,0.3319623818155308,"['ACTN2', 'ACTN1', 'DSC2']",0.8764270499954058,0,0,3
349,p38 MAPK Signaling Pathway WP400,0.6802997748905475,0.861194605009634,0.3317508777860128,"['SHC1', 'HSPB1']",0.8764270499954058,0,0,2
350,AGE/RAGE pathway WP2324,0.693660635215402,0.8422403381642513,0.3080683004595651,"['LGALS3', 'JUN', 'SHC1']",0.8764270499954058,0,0,3
351,Regulatory circuits of the STAT3 signaling pathway WP4538,0.693660635215402,0.8422403381642513,0.3080683004595651,"['IFNAR2', 'SOCS3', 'OSMR']",0.8764270499954058,0,0,3
352,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6966942593325701,0.8333395487600224,0.30117609362396697,"['JUN', 'HSPB1']",0.8764270499954058,0,0,2
353,Integrated Cancer Pathway WP1971,0.6966942593325701,0.8333395487600224,0.30117609362396697,"['BARD1', 'CDKN1A']",0.8764270499954058,0,0,2
354,Microglia Pathogen Phagocytosis Pathway WP3937,0.6967893427112904,0.8613548883756736,0.3111835308664212,['PIK3CD'],0.8764270499954058,0,0,1
355,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6967893427112904,0.8613548883756736,0.3111835308664212,['PIK3CD'],0.8764270499954058,0,0,1
356,Oxidative phosphorylation WP623,0.7067979396042566,0.8242464539007093,0.28602213588351505,"['NDUFA7', 'NDUFA4', 'NDUFA2']",0.8764270499954058,0,0,3
357,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7074201569425297,0.8329533136470676,0.2883105537687818,"['EGF', 'PIK3CD', 'NRG1', 'MAP3K14']",0.8764270499954058,0,0,4
358,G13 Signaling Pathway WP524,0.7123862177228257,0.8072254335260116,0.2737584571463996,"['PIK3CD', 'PIP4K2A']",0.8764270499954058,0,0,2
359,Nephrotic syndrome WP4758,0.7123862177228257,0.8072254335260116,0.2737584571463996,"['PLCE1', 'MYH9']",0.8764270499954058,0,0,2
360,Mesodermal commitment pathway WP2857,0.714873107319831,0.841690652931374,0.2825136564629097,"['SMAD1', 'ARL4A', 'FZD4', 'PBX3', 'HMGA2', 'RPL38']",0.8764270499954058,0,0,6
361,Angiogenesis WP1539,0.7185962668899727,0.8074480369515011,0.26682572494843654,['SMAD1'],0.8764270499954058,0,0,1
362,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.7185962668899727,0.8074480369515011,0.26682572494843654,['SHC1'],0.8764270499954058,0,0,1
363,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.7185962668899727,0.8074480369515011,0.26682572494843654,['MRAS'],0.8764270499954058,0,0,1
364,Kallmann's Syndrome WP5074,0.7185962668899727,0.8074480369515011,0.26682572494843654,['PRKCQ'],0.8764270499954058,0,0,1
365,One-carbon metabolism WP241,0.7185962668899727,0.8074480369515011,0.26682572494843654,['GLRX'],0.8764270499954058,0,0,1
366,Corticotropin-releasing hormone signaling pathway WP2355,0.7293952782614639,0.8067786790266512,0.25457052008236636,"['IL18', 'PRKCQ', 'JUNB', 'FOSL2']",0.8764270499954058,0,0,4
367,Hepatitis B infection WP4666,0.7364148348345605,0.8285150416044378,0.2534938579694441,"['JUN', 'CDKN1A', 'EGR3', 'IRF7', 'NFATC2', 'PIK3CD', 'TAB2']",0.8764270499954058,0,0,7
368,Ebstein-Barr virus LMP1 signaling WP262,0.7388365056681179,0.7598831680478196,0.23000038848820437,['MAP3K14'],0.8764270499954058,0,0,1
369,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7388365056681179,0.7598831680478196,0.23000038848820437,['SREBF1'],0.8764270499954058,0,0,1
370,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7388365056681179,0.7598831680478196,0.23000038848820437,['RPS6'],0.8764270499954058,0,0,1
371,Gastric Cancer Network 2 WP2363,0.7388365056681179,0.7598831680478196,0.23000038848820437,['S100A6'],0.8764270499954058,0,0,1
372,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.7388365056681179,0.7598831680478196,0.23000038848820437,['ETV6'],0.8764270499954058,0,0,1
373,Immune response to tuberculosis WP4197,0.7388365056681179,0.7598831680478196,0.23000038848820437,['IFNAR2'],0.8764270499954058,0,0,1
374,Urea cycle and associated pathways WP4595,0.7388365056681179,0.7598831680478196,0.23000038848820437,['GPT'],0.8764270499954058,0,0,1
375,B Cell Receptor Signaling Pathway WP23,0.7399099003987533,0.7942953917461449,0.23926310392038394,"['JUN', 'BCL6', 'SHC1', 'NFATC2']",0.8764270499954058,0,0,4
376,Hedgehog Signaling Pathway WP4249,0.7417287148638404,0.75960557633458,0.226948661569224,"['EVC2', 'GPR161']",0.8764270499954058,0,0,2
377,PDGF Pathway WP2526,0.7417287148638404,0.75960557633458,0.226948661569224,"['JUN', 'SHC1']",0.8764270499954058,0,0,2
378,AMP-activated protein kinase (AMPK) signaling WP1403,0.7436111607313775,0.7745833333333333,0.22946025391192787,"['SREBF1', 'CDKN1A', 'PIK3CD']",0.8764270499954058,0,0,3
379,Pathways affected in adenoid cystic carcinoma WP3651,0.7436111607313775,0.7745833333333333,0.22946025391192787,"['NOTCH1', 'MYCBP', 'ERBIN']",0.8764270499954058,0,0,3
380,Hippo-Merlin Signaling Dysregulation WP4541,0.750112042680834,0.7821903858983813,0.22490530838413572,"['PPP1R14A', 'PRKAR2B', 'FGFR3', 'CD44']",0.8764270499954058,0,0,4
381,Cannabinoid receptor signaling WP3869,0.7576224943293618,0.7176032845778805,0.1991851767002932,['PRKAR2B'],0.8764270499954058,0,0,1
382,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7576224943293618,0.7176032845778805,0.1991851767002932,['IRAK2'],0.8764270499954058,0,0,1
383,Glycerolipids and Glycerophospholipids WP4722,0.7576224943293618,0.7176032845778805,0.1991851767002932,['PNPLA3'],0.8764270499954058,0,0,1
384,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7576224943293618,0.7176032845778805,0.1991851767002932,['RPS6'],0.8764270499954058,0,0,1
385,Hippo-Yap signaling pathway WP4537,0.7576224943293618,0.7176032845778805,0.1991851767002932,['NDRG1'],0.8764270499954058,0,0,1
386,IL-7 signaling pathway WP205,0.7576224943293618,0.7176032845778805,0.1991851767002932,['IL7'],0.8764270499954058,0,0,1
387,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.7576224943293618,0.7176032845778805,0.1991851767002932,['NAMPT'],0.8764270499954058,0,0,1
388,PKC-gamma calcium signaling pathway in ataxia WP4760,0.7576224943293618,0.7176032845778805,0.1991851767002932,['GNA14'],0.8764270499954058,0,0,1
389,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7576224943293618,0.7176032845778805,0.1991851767002932,['NFATC2'],0.8764270499954058,0,0,1
390,One-carbon metabolism and related pathways WP3940,0.7684709583017224,0.7172768143866409,0.18889664715682802,"['SOD2', 'GCLM']",0.8829781608075252,0,0,2
391,Endothelin Pathways WP2197,0.7750586078199387,0.6797739151574085,0.1732176978787557,['EDNRA'],0.8829781608075252,0,0,1
392,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7750586078199387,0.6797739151574085,0.1732176978787557,['HGF'],0.8829781608075252,0,0,1
393,Fatty Acid Biosynthesis WP357,0.7750586078199387,0.6797739151574085,0.1732176978787557,['SCD'],0.8829781608075252,0,0,1
394,Sphingolipid Metabolism (general overview) WP4725,0.7750586078199387,0.6797739151574085,0.1732176978787557,['UGCG'],0.8829781608075252,0,0,1
395,Toll-like Receptor Signaling related to MyD88 WP3858,0.7750586078199387,0.6797739151574085,0.1732176978787557,['IRF7'],0.8829781608075252,0,0,1
396,Estrogen signaling pathway WP712,0.7912417377944873,0.6457274826789838,0.15119821850657647,['JUN'],0.8896415816985915,0,0,1
397,Pre-implantation embryo WP3527,0.7912417377944873,0.6457274826789838,0.15119821850657647,['ZFP36'],0.8896415816985915,0,0,1
398,SARS-CoV-2 mitochondrial interactions WP5038,0.7912417377944873,0.6457274826789838,0.15119821850657647,['IRF7'],0.8896415816985915,0,0,1
399,Sphingolipid Metabolism (integrated pathway) WP4726,0.7912417377944873,0.6457274826789838,0.15119821850657647,['UGCG'],0.8896415816985915,0,0,1
400,Trans-sulfuration and one-carbon metabolism WP2525,0.7912417377944873,0.6457274826789838,0.15119821850657647,['GCLM'],0.8896415816985915,0,0,1
401,Pathogenic Escherichia coli infection WP2272,0.7927694983580782,0.6794037115911166,0.15777301186666678,"['TUBB6', 'TUBB2B']",0.8896415816985915,0,0,2
402,Eukaryotic Transcription Initiation WP405,0.8040532328980792,0.6619238179931821,0.14435883435406563,"['POLR2I', 'POLR2K']",0.8978261905809818,0,0,2
403,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8040532328980792,0.6619238179931821,0.14435883435406563,"['CP', 'FTL']",0.8978261905809818,0,0,2
404,Physiological and pathological hypertrophy of the heart WP1528,0.8062618287690188,0.6149235675794568,0.1324217854050243,['JUN'],0.898063918183313,0,0,1
405,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8249927273112596,0.6295220640067672,0.12110790041717136,"['RNF125', 'IRF7']",0.9144008061331695,0,0,2
406,Synaptic Vesicle Pathway WP2267,0.8249927273112596,0.6295220640067672,0.12110790041717136,"['SNAP25', 'RIMS1']",0.9144008061331695,0,0,2
407,Glycerophospholipid Biosynthetic Pathway WP2533,0.8331408851896199,0.5613515413194096,0.10247613916793452,['PIK3CD'],0.9189053880767868,0,0,1
408,Sphingolipid pathway WP1422,0.8331408851896199,0.5613515413194096,0.10247613916793452,['UGCG'],0.9189053880767868,0,0,1
409,DNA IR-damage and cellular response via ATR WP4016,0.8402214144787713,0.6449074074074074,0.11227182299335968,"['BARD1', 'BCL6', 'PML']",0.9221942354035295,0,0,3
410,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8402214144787713,0.6449074074074074,0.11227182299335968,"['NOTCH1', 'RPS6', 'PRKCQ']",0.9221942354035295,0,0,3
411,BDNF-TrkB Signaling WP3676,0.8451493061486113,0.5379137798306389,0.09049967592729825,['SHC1'],0.9253459556371656,0,0,1
412,Nuclear receptors WP170,0.8562944263791771,0.5163510392609699,0.08010721964357409,['RXRG'],0.9330084548925659,0,0,1
413,Proximal tubule transport WP4917,0.8562944263791771,0.5163510392609699,0.08010721964357409,['SLC3A1'],0.9330084548925659,0,0,1
414,Leptin signaling pathway WP2034,0.8622870118676044,0.6140321869488536,0.09097937049417835,"['SOCS3', 'SHC1', 'RPS6']",0.9372684911604395,0,0,3
415,Amino Acid metabolism WP3925,0.8690239226226598,0.6043836805555556,0.08484617646321096,"['WARS', 'P4HA2', 'GCLM']",0.9400499162985502,0,0,3
416,Pathways Regulating Hippo Signaling WP4540,0.8690239226226598,0.6043836805555556,0.08484617646321096,"['PRKAR2B', 'PRKCQ', 'FGFR3']",0.9400499162985502,0,0,3
417,Glioblastoma signaling pathways WP2261,0.8754683061064124,0.5950320512820513,0.07913707834952013,"['CDKN1A', 'PIK3CD', 'PRKCQ']",0.9447499706184306,0,0,3
418,Development of ureteric collection system WP5053,0.8851480349761202,0.4609039920818212,0.056230460703993845,['SMAD1'],0.9506363144134943,0,0,1
419,miRNA regulation of prostate cancer signaling pathways WP3981,0.8851480349761202,0.4609039920818212,0.056230460703993845,['CDKN1A'],0.9506363144134943,0,0,1
420,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8934170192714459,0.444970932547583,0.05014903405376019,['TNFRSF1A'],0.9526715755567733,0,0,1
421,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8934170192714459,0.444970932547583,0.05014903405376019,['RPS6'],0.9526715755567733,0,0,1
422,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8963218228425991,0.5157919075144509,0.056456391739834265,"['FN1', 'ANGPTL1']",0.9526715755567733,0,0,2
423,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9010912883154921,0.4301000769822941,0.044794367165438026,['NFATC2'],0.9526715755567733,0,0,1
424,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9010912883154921,0.4301000769822941,0.044794367165438026,['SHC1'],0.9526715755567733,0,0,1
425,3q29 copy number variation syndrome WP4906,0.9023104571663557,0.5056330046469455,0.051977369194123484,"['JUN', 'SLC51A']",0.9526715755567733,0,0,2
426,Amyotrophic lateral sclerosis (ALS) WP2447,0.9082135686974572,0.4161886314534754,0.040068860241093365,['TNFRSF1A'],0.9526715755567733,0,0,1
427,MAPK Cascade WP422,0.9082135686974572,0.4161886314534754,0.040068860241093365,['JUN'],0.9526715755567733,0,0,1
428,NO/cGMP/PKG mediated Neuroprotection WP4008,0.9082135686974572,0.4161886314534754,0.040068860241093365,['ACTN2'],0.9526715755567733,0,0,1
429,Parkinson's disease pathway WP2371,0.9082135686974572,0.4161886314534754,0.040068860241093365,['CCNE2'],0.9526715755567733,0,0,1
430,Copper homeostasis WP3286,0.9209579583366835,0.3908950941283505,0.03218665057714073,['JUN'],0.9603028427753328,0,0,1
431,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9209579583366835,0.3908950941283505,0.03218665057714073,['ACTA2'],0.9603028427753328,0,0,1
432,Androgen receptor signaling pathway WP138,0.9218907290643195,0.522240990990991,0.04247311694272059,"['CDKN1A', 'JUN', 'LIMK2']",0.9603028427753328,0,0,3
433,ATM Signaling Network in Development and Disease  WP3878,0.9456111779245304,0.33930959037316155,0.018975485542987586,['HSPB1'],0.9827367899908515,0,0,1
434,Thermogenesis WP4321,0.9545291679263969,0.45965608465608465,0.02139105104311883,"['RPS6KA2', 'RPS6', 'ADCY2']",0.9895263704963475,0,0,3
435,Wnt Signaling Pathway WP363,0.9565421581464691,0.3143975666084605,0.013968814562364724,['NFATC2'],0.9895263704963475,0,0,1
436,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9596742633691007,0.30688441658418564,0.012631780283638141,['PIK3CD'],0.9904894920093928,0,0,1
437,Ciliopathies WP4803,0.967825285411595,0.5241650667235536,0.017142136187462204,"['EVC2', 'DNAH11', 'GPR161', 'SPAG1', 'CCDC65', 'CCDC28B']",0.9947929858952675,0,0,6
438,Translation Factors WP107,0.9701040404826959,0.28009840345416204,0.008501534139139013,['EEF1B2'],0.9947929858952675,0,0,1
439,Rett syndrome causing genes WP4312,0.9722595497113348,0.2741142941378802,0.007711515915862122,['SYNE2'],0.9947929858952675,0,0,1
440,Male infertility WP4673,0.9732519468940124,0.3574823378291586,0.009692165559786498,"['NQO1', 'SOD2']",0.9947929858952675,0,0,2
441,Integrin-mediated Cell Adhesion WP185,0.9748971261773621,0.3525536463694671,0.008963085989402576,"['CAV3', 'SHC1']",0.9947929858952675,0,0,2
442,DNA Repair Pathways Full Network WP4946,0.9805214756561013,0.3894851290684624,0.0076614571345103065,"['POLE4', 'POLD4', 'RPA3']",0.9972582211337542,0,0,3
443,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9838832953950687,0.41756399024013413,0.006784576040724842,"['JUN', 'SHC1', 'RPS6', 'IRS2']",0.9972582211337542,0,0,4
444,7q11.23 copy number variation syndrome WP4932,0.9839614448519707,0.3215028901734104,0.0051982402998220715,"['SNAP25', 'NRG1']",0.9972582211337542,0,0,2
445,Alzheimer's disease WP2059,0.9916286482614004,0.20420469958576193,0.0017166648369327838,['TNFRSF1A'],0.9999906005414493,0,0,1
446,Endoderm differentiation WP2853,0.9939703586994766,0.2703742013994524,0.0016351942378746505,"['NOTCH1', 'PBX3']",0.9999906005414493,0,0,2
447,Pathways in clear cell renal cell carcinoma WP4018,0.9946600846590491,0.18634735749907955,0.000997745428333449,['ENPP3'],0.9999906005414493,0,0,1
448,Genes related to primary cilium development (based on CRISPR) WP4536,0.999344913038274,0.13222304230851648,8.664597447975081e-05,['EVC2'],0.9999906005414493,0,0,1
449,Fragile X Syndrome  WP4549,0.9997694294649124,0.11540062001955767,2.661105068735166e-05,['SHC1'],0.9999906005414493,0,0,1
450,Ciliary landscape WP4352,0.9999906005414493,0.1298572608234045,1.2205936770882488e-06,"['CDH23', 'MAPRE2']",0.9999906005414493,0,0,2
